查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2069217

寵物繁殖和絕育市場預測——全球產品類型、動物種類、技術、應用、最終用戶和地區分析——2034年

Pet Fertility Management Market Forecasts to 2034 - Global Analysis By Product Type, Animal Type, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

全球寵物繁殖和絕育市場預計到 2026 年將達到 7 億美元，並在預測期內以 9.0% 的複合年成長率成長，到 2034 年將達到 14 億美元。

寵物繁殖和絕育服務包括透過專業的獸醫護理、診斷技術和生殖醫學解決方案，監測、評估和最佳化伴侶動物的生殖健康和繁殖成果。這包括生育力評估、荷爾蒙檢測、基因篩檢、生殖週期追蹤、人工授精、懷孕管理和繁殖支持服務。寵物繁殖和絕育服務的目標是在確保動物福利標準的前提下，提高繁殖效率，支持負責任的繁殖計劃，促進幼犬健康，並確保最佳的繁殖效果。

對純種育種的需求日益成長

全球對純種伴侶動物的需求持續推動著對先進繁殖管理技術的巨額投資。專業繁殖者需要精準的排卵時間和基因篩檢來維持品種標準和優良性狀。犬舍俱樂部和品種協會正日益強制要求實施包含生育力評估的健康檢測方案。商業性繁殖產業依賴人工授精和胚胎移植來跨越地理界限，充分利用優良的遺傳品質。發展中國家寵物數量的不斷成長，也催生了對繁殖服務及相關繁殖管理產品的持續需求。

高昂的治療費用

體外受精和胚胎移植等先進的繁殖管理技術費用昂貴，因此一般寵物飼主難以負擔。繁殖技術所需的專業獸醫知識集中在都市區的轉診醫院，造成了地理上的進入障礙。輔助生殖技術的設備和耗材需要動物醫院投入大量資金。此外，大多數市場對繁殖獸醫服務的保險覆蓋範圍仍然有限。由於這些成本和准入方面的限制，市場滲透率僅限於商業性繁殖企業和高價值的比賽動物。

遺傳資源保護服務

保存珍貴種畜遺傳資源的市場不斷擴大，為冷凍保存和長期生殖細胞保存服務帶來了巨大的商機。競技動物的飼主正努力保存冠軍馬、犬隻和珍稀動物的遺傳資源，以用於未來的育種計畫。玻璃化冷凍技術的進步提高了保存的生殖細胞和胚胎解凍後的存活率。商業性基因庫提供基於訂閱的保存服務，從而產生持續的收入。寵物飼主對已故寵物的深厚感情也推動了對死後基因保存作為紀念方式的需求。

倫理和福利問題

集約化繁殖方式和輔助生殖技術正面臨動物福利組織和監管機構日益嚴格的審查。過度繁殖、遺傳多樣性喪失以及對母體健康的影響等問題已成為生殖保健產業的聲譽風險。一些歐洲司法管轄區已訂定立法，限制伴侶動物的某些輔助生殖技術。公眾對商業性繁殖活動的反對也延伸至能夠實現大規模生產的生殖技術。這些倫理挑戰可能導致監管限制，從而阻礙某些生殖保健應用領域的市場成長。

新型冠狀病毒（COVID-19）的影響：

新冠疫情期間，由於動物醫院在封鎖期間暫停了非緊急手術，獸醫繁殖服務受到衝擊。然而，疫情期間寵物領養數量的激增延緩了對繁殖服務的需求，隨後幾年該需求強勁復甦。供應鏈中斷影響了繁殖手術所需的荷爾蒙製劑和一次性設備的供應。疫情後，寵物飼養量的持續成長鞏固了對伴侶動物繁殖的需求，而繁殖管理技術也為此提供了支持。這次危機凸顯了建立一條具有韌性的獸醫繁殖健康產品供應鏈的重要性。

在預測期內，荷爾蒙療法領域預計將佔據最大的市場佔有率。

鑑於荷爾蒙療法在多種動物物種中廣泛用於調節生殖週期，預計在預測期內，荷爾蒙療法領域將佔據最大的市場佔有率。荷爾蒙療法，包括前列腺素、促性腺激素分泌和黃體素製劑，是生殖支持和避孕的基礎治療方法。製藥公司透過獸藥批發商和直接銷售管道，維持完善的分銷網路，直接面向動物醫院。用於週期同步和妊娠維持的荷爾蒙療法需要反覆進行，從而產生了持續的需求。由於監管機構對荷爾蒙療法的了解不斷加深，其核准流程相比於其他新興生殖技術正在加速推進。

預計在預測期內，體外受精（IVF）領域將呈現最高的複合年成長率。

在預測期內，體外受精（IVF）領域預計將呈現最高的成長率，這主要得益於輔助生殖技術在伴侶動物領域成功率的提升。 IVF技術透過採集和儲存配子，能夠保存已死亡或身患絕症的珍貴種畜的基因。這項技術無需動物運輸即可促進國際基因交流。研究機構正在開發物種特異性的IVF方案，以拓展其在傳統畜牧業以外的應用。專業育種者對IVF潛力的認知不斷提高，正在加速其在珍稀瀕危伴侶動物物種中的應用。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這主要得益於其先進的獸醫基礎設施和在純種動物繁殖行業的重要地位。美國憑藉其龐大的認證獸醫生殖專家和轉診中心網路，在該領域處於領先地位。總部位於北美的主要動物用藥品公司在全球開​​發和銷售荷爾蒙生育產品。該地區活躍的馬和犬繁殖產業對生育管理服務有著穩定的需求。此外，成熟的寵物保險市場正在擴大其對生殖醫療程序的承保範圍。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於伴侶動物飼養量的成長和獸醫專業服務的蓬勃發展。在中國，不斷壯大的中產階級推動了對純種犬貓的需求，而生殖保健服務也為此提供了支持。澳洲擁有先進的出口導向馬匹養殖業，這需要先進的生殖技術。在日本，寵物老化催生了對輔助生殖技術的需求，以保存愛寵的基因。在韓國，新興的寵物文化正在促進對提供生殖服務的獸醫診所的投資。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域分類
    • 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需經可行性確認）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章：全球寵物繁殖與絕育市場：依產品類型分類

  • 荷爾蒙製劑
  • 精液分析及加工產品
  • 排卵和懷孕檢測套組
  • 人工授精試劑盒
  • 胚胎移植裝置

第6章：全球寵物繁殖與絕育市場：依動物類型分類

  • 狗
  • 貓
  • 馬
  • 微型線軸
  • 異域伴侶動物

第7章 全球寵物繁殖與絕育市場：依技術分類

  • 人工授精
  • 胚胎移植
  • 體外受精
  • 荷爾蒙同步
  • 超音波檢查
  • 冷凍保存

第8章 全球寵物繁殖與絕育市場：依應用分類

  • 育種管理
  • 不孕症治療
  • 遺傳資源的保護
  • 避孕
  • 妊娠監測

第9章 全球寵物繁殖與絕育市場：依最終使用者分類

  • 動物醫院
  • 動物繁殖中心
  • 研究機構
  • 動物收容所
  • 個體育種者

第10章：全球寵物繁殖與絕育市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第11章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第12章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第13章：公司簡介

  • Zoetis Inc.
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Elanco Animal Health Incorporated
  • Virbac SA
  • Vetoquinol SA
  • Dechra Pharmaceuticals PLC
  • IdePet Fertility Management Laboratories, Inc.
  • Neogen Corporation
  • IMV Technologies
  • Minitube International
  • Hamilton Thorne, Ltd.
  • Microptic SL
  • Coopersurgical Inc.
  • Ceva Sante Animale
  • Agtech Inc.
Product Code: SMRC37234

According to Stratistics MRC, the Global Pet Fertility Management Market is accounted for $0.7 billion in 2026 and is expected to reach $1.4 billion by 2034 growing at a CAGR of 9.0% during the forecast period. Pet Fertility Management refers to the monitoring, assessment, and optimization of reproductive health and breeding outcomes in companion animals through specialized veterinary practices, diagnostic technologies, and reproductive healthcare solutions. It encompasses fertility evaluation, hormonal testing, genetic screening, reproductive cycle tracking, artificial insemination, pregnancy management, and breeding support services. Pet fertility management aims to improve reproductive efficiency, support responsible breeding programs, enhance offspring health, and ensure optimal reproductive performance while maintaining animal welfare standards.

Market Dynamics:

Driver:

Rising purebred breeding demand

The global demand for purebred companion animals continues to drive substantial investment in advanced fertility management technologies. Professional breeders require precise ovulation timing and genetic screening to maintain breed standards and desirable traits. Kennel clubs and breed associations increasingly mandate health testing protocols that incorporate fertility assessments. The commercial breeding industry relies on artificial insemination and embryo transfer to access superior genetics across geographic boundaries. Rising pet ownership in developing markets creates sustained demand for breeding services supported by fertility management products.

Restraint:

High procedural costs

Advanced fertility management procedures such as in-vitro fertilization and embryo transfer involve significant costs that limit accessibility for individual pet owners. Specialized veterinary expertise required for reproductive procedures is concentrated in urban referral centers, creating geographic access barriers. The equipment and consumables for assisted reproduction represent substantial capital investment for veterinary practices. Insurance coverage for fertility-related veterinary services remains limited in most markets. These cost and access constraints restrict market penetration beyond commercial breeding operations and high-value performance animals.

Opportunity:

Genetic preservation services

The expanding market for genetic preservation of valuable breeding animals creates significant opportunities for cryopreservation and long-term fertility storage services. Performance animal owners seek to preserve genetics from champion horses, dogs, and exotic species for future breeding programs. Advances in vitrification techniques improve post-thaw viability of preserved gametes and embryos. Commercial genetic banks offer subscription-based storage services that generate recurring revenue. The emotional attachment of pet owners to deceased animals drives demand for post-mortem genetic preservation as a memorial service.

Threat:

Ethical and welfare concerns

Intensive breeding practices and assisted reproduction technologies face growing scrutiny from animal welfare organizations and regulatory bodies. Concerns regarding overbreeding, genetic diversity loss, and maternal health impacts create reputational risks for the fertility management industry. Legislative proposals in several European jurisdictions seek to restrict certain assisted reproduction techniques in companion animals. Public opposition to commercial breeding operations extends to the fertility technologies that enable large-scale production. These ethical challenges may result in regulatory constraints that limit market growth for certain fertility management applications.

Covid-19 Impact:

The COVID-19 pandemic disrupted veterinary reproductive services as clinics suspended non-essential procedures during lockdown periods. However, the surge in pet adoption during the crisis created deferred demand for breeding services that rebounded strongly in subsequent years. Supply chain disruptions affected the availability of hormonal products and disposable equipment for fertility procedures. Post-pandemic, the sustained increase in pet ownership has generated lasting demand for companion animal breeding supported by fertility management technologies. The crisis highlighted the importance of resilient veterinary supply chains for reproductive health products.

The hormonal products segment is expected to be the largest during the forecast period

The hormonal products segment is expected to account for the largest market share during the forecast period, due to widespread use in regulating reproductive cycles across multiple animal species. Hormonal therapies including prostaglandins, gonadotropins, and progesterone formulations represent foundational treatments for both breeding support and contraception. Pharmaceutical manufacturers maintain established distribution networks through veterinary wholesalers and direct-to-practice channels. The recurring nature of hormonal treatments for cycle synchronization and pregnancy maintenance generates sustained demand. Regulatory familiarity with hormonal products facilitates faster approval pathways compared to novel fertility technologies.

The In-vitro fertilization segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the In-vitro fertilization segment is predicted to witness the highest growth rate, driven by technological advances that improve success rates in companion animal assisted reproduction. IVF enables genetic rescue from deceased or terminally ill valuable breeding animals through gamete collection and storage. The technique supports international genetic exchange without requiring animal transport. Research institutions develop species-specific IVF protocols that expand applicability beyond traditional livestock applications. Growing awareness among specialty breeders regarding IVF capabilities accelerates adoption for rare and endangered companion animal breeds.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to advanced veterinary infrastructure and substantial purebred breeding industry presence. The United States leads with extensive network of board-certified veterinary reproduction specialists and referral centers. Major animal health pharmaceutical companies headquartered in North America develop and distribute hormonal fertility products globally. Strong equine and canine breeding industries in the region generate consistent demand for fertility management services. Well-established pet insurance markets increasingly cover reproductive health procedures.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to expanding companion animal ownership and developing veterinary specialty services. China's growing middle class drives demand for purebred dogs and cats supported by fertility management. Australia maintains advanced equine breeding industry with significant export orientation requiring reproductive technologies. Japan's aging pet population creates demand for assisted reproduction to preserve valued companion animal genetics. South Korea's emerging pet culture supports investment in veterinary specialty clinics offering fertility services.

Key players in the market

Some of the key players in Pet Fertility Management Market include Zoetis Inc., Merck & Co., Inc., Boehringer Ingelheim International GmbH, Elanco Animal Health Incorporated, Virbac S.A., Vetoquinol S.A., Dechra Pharmaceuticals PLC, IdePet Fertility Management Laboratories, Inc., Neogen Corporation, IMV Technologies, Minitube International, Hamilton Thorne, Ltd., Microptic S.L., Coopersurgical Inc., Ceva Sante Animale and Agtech Inc.

Key Developments:

In June 2026, Zoetis Inc. launched an advanced canine ovulation monitoring system integrating AI-driven hormonal analysis with real-time mobile alerts for veterinary breeding specialists.

In May 2026, Merck & Co., Inc. expanded its fertility pharmaceutical portfolio with a next-generation progesterone formulation designed for extended-release cycle synchronization in equine breeding programs.

In March 2026, Hamilton Thorne, Ltd. introduced a compact benchtop semen analysis system with automated motility scoring and morphology assessment for veterinary clinic deployment.

Product Types Covered:

  • Hormonal Products
  • Semen Analysis and Processing Products
  • Ovulation and Pregnancy Detection Kits
  • Artificial Insemination Kits
  • Embryo Transfer Equipment

Animal Types Covered:

  • Canine
  • Feline
  • Equine
  • Bovine Companion
  • Exotic Companion Animals

Technologies Covered:

  • Artificial Insemination
  • Embryo Transfer
  • In-Vitro Fertilization
  • Hormonal Synchronization
  • Ultrasonography
  • Cryopreservation

Applications Covered:

  • Breeding Management
  • Infertility Treatment
  • Genetic Preservation
  • Contraception Management
  • Pregnancy Monitoring

End Users Covered:

  • Veterinary Hospitals
  • Animal Breeding Centers
  • Research Institutes
  • Animal Shelters
  • Individual Breeders

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Pet Fertility Management Market, By Product Type

  • 5.1 Hormonal Products
  • 5.2 Semen Analysis and Processing Products
  • 5.3 Ovulation and Pregnancy Detection Kits
  • 5.4 Artificial Insemination Kits
  • 5.5 Embryo Transfer Equipment

6 Global Pet Fertility Management Market, By Animal Type

  • 6.1 Canine
  • 6.2 Feline
  • 6.3 Equine
  • 6.4 Bovine Companion
  • 6.5 Exotic Companion Animals

7 Global Pet Fertility Management Market, By Technology

  • 7.1 Artificial Insemination
  • 7.2 Embryo Transfer
  • 7.3 In-Vitro Fertilization
  • 7.4 Hormonal Synchronization
  • 7.5 Ultrasonography
  • 7.6 Cryopreservation

8 Global Pet Fertility Management Market, By Application

  • 8.1 Breeding Management
  • 8.2 Infertility Treatment
  • 8.3 Genetic Preservation
  • 8.4 Contraception Management
  • 8.5 Pregnancy Monitoring

9 Global Pet Fertility Management Market, By End User

  • 9.1 Veterinary Hospitals
  • 9.2 Animal Breeding Centers
  • 9.3 Research Institutes
  • 9.4 Animal Shelters
  • 9.5 Individual Breeders

10 Global Pet Fertility Management Market, By Geography

  • 10.1 North America
    • 10.1.1 United States
    • 10.1.2 Canada
    • 10.1.3 Mexico
  • 10.2 Europe
    • 10.2.1 United Kingdom
    • 10.2.2 Germany
    • 10.2.3 France
    • 10.2.4 Italy
    • 10.2.5 Spain
    • 10.2.6 Netherlands
    • 10.2.7 Belgium
    • 10.2.8 Sweden
    • 10.2.9 Switzerland
    • 10.2.10 Poland
    • 10.2.11 Rest of Europe
  • 10.3 Asia Pacific
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 South Korea
    • 10.3.5 Australia
    • 10.3.6 Indonesia
    • 10.3.7 Thailand
    • 10.3.8 Malaysia
    • 10.3.9 Singapore
    • 10.3.10 Vietnam
    • 10.3.11 Rest of Asia Pacific
  • 10.4 South America
    • 10.4.1 Brazil
    • 10.4.2 Argentina
    • 10.4.3 Colombia
    • 10.4.4 Chile
    • 10.4.5 Peru
    • 10.4.6 Rest of South America
  • 10.5 Rest of the World (RoW)
    • 10.5.1 Middle East
      • 10.5.1.1 Saudi Arabia
      • 10.5.1.2 United Arab Emirates
      • 10.5.1.3 Qatar
      • 10.5.1.4 Israel
      • 10.5.1.5 Rest of Middle East
    • 10.5.2 Africa
      • 10.5.2.1 South Africa
      • 10.5.2.2 Egypt
      • 10.5.2.3 Morocco
      • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

  • 11.1 Industry Value Network and Supply Chain Assessment
  • 11.2 White-Space and Opportunity Mapping
  • 11.3 Product Evolution and Market Life Cycle Analysis
  • 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

  • 12.1 Mergers and Acquisitions
  • 12.2 Partnerships, Alliances, and Joint Ventures
  • 12.3 New Product Launches and Certifications
  • 12.4 Capacity Expansion and Investments
  • 12.5 Other Strategic Initiatives

13 Company Profiles

  • 13.1 Zoetis Inc.
  • 13.2 Merck & Co., Inc.
  • 13.3 Boehringer Ingelheim International GmbH
  • 13.4 Elanco Animal Health Incorporated
  • 13.5 Virbac S.A.
  • 13.6 Vetoquinol S.A.
  • 13.7 Dechra Pharmaceuticals PLC
  • 13.8 IdePet Fertility Management Laboratories, Inc.
  • 13.9 Neogen Corporation
  • 13.10 IMV Technologies
  • 13.11 Minitube International
  • 13.12 Hamilton Thorne, Ltd.
  • 13.13 Microptic S.L.
  • 13.14 Coopersurgical Inc.
  • 13.15 Ceva Sante Animale
  • 13.16 Agtech Inc.

List of Tables

  • Table 1 Global Pet Fertility Management Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Pet Fertility Management Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 3 Global Pet Fertility Management Market Outlook, By Hormonal Products (2023-2034) ($MN)
  • Table 4 Global Pet Fertility Management Market Outlook, By Semen Analysis and Processing Products (2023-2034) ($MN)
  • Table 5 Global Pet Fertility Management Market Outlook, By Ovulation and Pregnancy Detection Kits (2023-2034) ($MN)
  • Table 6 Global Pet Fertility Management Market Outlook, By Artificial Insemination Kits (2023-2034) ($MN)
  • Table 7 Global Pet Fertility Management Market Outlook, By Embryo Transfer Equipment (2023-2034) ($MN)
  • Table 8 Global Pet Fertility Management Market Outlook, By Animal Type (2023-2034) ($MN)
  • Table 9 Global Pet Fertility Management Market Outlook, By Canine (2023-2034) ($MN)
  • Table 10 Global Pet Fertility Management Market Outlook, By Feline (2023-2034) ($MN)
  • Table 11 Global Pet Fertility Management Market Outlook, By Equine (2023-2034) ($MN)
  • Table 12 Global Pet Fertility Management Market Outlook, By Bovine Companion (2023-2034) ($MN)
  • Table 13 Global Pet Fertility Management Market Outlook, By Exotic Companion Animals (2023-2034) ($MN)
  • Table 14 Global Pet Fertility Management Market Outlook, By Technology (2023-2034) ($MN)
  • Table 15 Global Pet Fertility Management Market Outlook, By Artificial Insemination (2023-2034) ($MN)
  • Table 16 Global Pet Fertility Management Market Outlook, By Embryo Transfer (2023-2034) ($MN)
  • Table 17 Global Pet Fertility Management Market Outlook, By In-Vitro Fertilization (2023-2034) ($MN)
  • Table 18 Global Pet Fertility Management Market Outlook, By Hormonal Synchronization (2023-2034) ($MN)
  • Table 19 Global Pet Fertility Management Market Outlook, By Ultrasonography (2023-2034) ($MN)
  • Table 20 Global Pet Fertility Management Market Outlook, By Cryopreservation (2023-2034) ($MN)
  • Table 21 Global Pet Fertility Management Market Outlook, By Application (2023-2034) ($MN)
  • Table 22 Global Pet Fertility Management Market Outlook, By Breeding Management (2023-2034) ($MN)
  • Table 23 Global Pet Fertility Management Market Outlook, By Infertility Treatment (2023-2034) ($MN)
  • Table 24 Global Pet Fertility Management Market Outlook, By Genetic Preservation (2023-2034) ($MN)
  • Table 25 Global Pet Fertility Management Market Outlook, By Contraception Management (2023-2034) ($MN)
  • Table 26 Global Pet Fertility Management Market Outlook, By Pregnancy Monitoring (2023-2034) ($MN)
  • Table 27 Global Pet Fertility Management Market Outlook, By End User (2023-2034) ($MN)
  • Table 28 Global Pet Fertility Management Market Outlook, By Veterinary Hospitals (2023-2034) ($MN)
  • Table 29 Global Pet Fertility Management Market Outlook, By Animal Breeding Centers (2023-2034) ($MN)
  • Table 30 Global Pet Fertility Management Market Outlook, By Research Institutes (2023-2034) ($MN)
  • Table 31 Global Pet Fertility Management Market Outlook, By Animal Shelters (2023-2034) ($MN)
  • Table 32 Global Pet Fertility Management Market Outlook, By Individual Breeders (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.